Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241163EnglishN2024February14Healthcare Modern Trends in Complex Treatment of Patients with the Cervical Cancer English0307O.V. BondarEnglish A.I. RybinEnglish K.M. DoikovaEnglish Introduction: Complex treatment of patients with the cervical cancer has been studied less. Aims: To assess the effectiveness of combined treatment (surgery + radiomodifier as chemotherapy and radiation therapy) in patients with cervical cancer. Methodology: Retrospective analysis of case histories of 661 patients with cervical cancer. Patients received treatment from 2015 to 2020. All women were divided into 2 subgroups: in the main (n = 336) surgery, radiomodifier and radiation therapy and the control group (n = 325), no radiomodifier was used. Results: An objective response after the first stage of treatment was achieved in 84.3% of patients in the main group and 59.4% of patients in the control group. Intra-systemic administration of cytostatics had a significant effect on the involution of infiltration in comparison with the effect of radiation only. In cases where neoplasm has not reduced, positive changes were observed: the exophytic part of the tumor, its bleeding and the volume of discharge decreased, superficial necrosis decreased or completely disappeared. Out of 336 patients from the main group IB2-III stage, 87% of patients are in remission for more than 3 years. Conclusion: The undeniable advantage combining radiation treatment with chemotherapy has been proven. Current standard may be considered as the weekly introduction of platinum preparations in the process of radiation treatment, as well as the use of fluoropyrimidine derivates as radio-modifying agents. Nature and extent of early complications did not differ reliably in comparison groups. EnglishCervical cancer, Gynecology, Chemoradiation therapy, Radiation therapy, X-ray, Radiomodifier.http://ijcrr.com/abstract.php?article_id=4790http://ijcrr.com/article_html.php?did=4790 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015;136(5): 359-386. 2. American Cancer Society: Cancer Facts and Figures 2020. Atlanta, Ga: American Cancer Society, 2020,4, tab1. 3. Fedorenko Zoja P., Michailovich Youriy Yo., Goulak Lyudmyla O., Gorokh Yevgeniy L., Ryzhov Anton Yu., Soumkina Olena V., et al. Bulletin of national cancer registry of Ukraine 2020; 21:6. 4. Fedorenko ZP., Michailovich Y Yo., Goulak LO., Gorokh YL., Ryzhov AYu., Soumkina OV., et al. Bulletin of nationl cancer registry of Ukraine 2020;21:10. 5. Myong ChL, Maria L, Seung HS. Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol. 2017; 28(3):22. 6. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018; 143(2):22. 7. Rose PG, Blessing JA, Mayer AR, Homesley HD. Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 1998;16(2):405-410. 8. Chino J, Annunziata CM, Beriwal S. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 2020; 10:220. 9. Vishnevskaya EE. Handbook of Oncology Gynecology. Minsk, Belarus. 2014. 10. Dexter LI., Maryanenko AI., Bohman YaV. Changes in clinical and immunological parameters in patients with cervical cancer under the influence of a polypeptide drug thymus (thymalin). Immunology of tumors. Riga: Zinatne, 2012. 150-152. 11. Bernardini M, Barrett J, Seaward G, Covens A. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol. 2003; 189: 1378–1382. 12. Boss EA, van Golde RJ, Beerendonk CC, Massuger LF. Pregnancy after radical trachelectomy: a real option. Gynecol Oncol. 2005; 99: 152–156 13. American College of Obstetricians and Gynecologists ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002; 78: 79–91. 14. Weinberg M, Radiation therapy. Retrospection, looking to the future. J Med Radio 1994$ 39 (3): 68-71. 15. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL, Gersell D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999; 340(15):1154-1161. 16. Stolyarova KV., Vinokurov VL., Zharinov GM. Results of polyradiomodification in radiation therapy for cancer of the cervix and uterine body. Med Radiol. 2012; 3-4: 273-281. 17. Bohman YaV., Vishnevsky AS., Maksimov SYa. Petersburg scale of oncogynecology: some results and prospects. Vopr. onkol. 1997; 43(1):39-46. 18. Narimatsu A., Ito T. Neoadjuvent chemotherapy with continuos intraarterial infusion fCDDP, 5Fu in the treatment of advance cervical and endometrial adenocarcinoma. J. Jap. Soc. Cancer Then 2005; 30(2): 408. 19. Vishnevskaya EE., Kosenko IA. Long-term results of complex therapy of patients with cervical cancer with a palate prognosis. Vopr. onkol. 2009; 45(4): 420-423. 20. Alvarez SA., Harvilevsky LJ., Bae JV. Gyneacol. Oncol. 2007; 107(2). 21. Krikunova LI., Mkrtchan LS., Shentereva NI., Sychenkova NI. Cervical cancer. Therapeutic Radiology: A Guide for Physicians. LLC “MK”, Moscow 2010; 369-378. 22. Stolyarova KV., Vinokurov VL., Zharinov GM. Results of polyradiomodification in radiation therapy for cancer of the cervix and uterine body. Med Radiol. 2012; 3-4: 281-292. 23. Greenlee R., Murray T., Bolden S. Cancer statistics. CA Cancer J. Clin. 2001; 36: 5115. 24. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Cervical cancer.